The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions

• Hoofdauteurs: Yanping Li (Auteur), Yue Ming (Auteur), Ruoqiu Fu (Auteur), Chen Li (Auteur), Yuanlin Wu (Auteur), Tingting Jiang (Auteur), Ziwei Li (Auteur), Rui Ni (Auteur), Li Li (Auteur), Hui Su (Auteur), Yao Liu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Chimeric antigen receptor (CAR)-T cell therapy is effective in the treatment of refractory/relapsed (r/r) hematological malignancies (r/r B-cell lymphoblastic leukemia, B-cell lymphoma, and multiple myeloma). In addition, it is being explored as a treatment option for solid tumors. As of 31 March 20...